T cell immunity to SARS-CoV-2
Open Access
- 21 October 2021
- journal article
- review article
- Published by Elsevier in Seminars in Immunology
- Vol. 55, 101505
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infectionJournal of Leukocyte Biology, 2013
- Why must T cells be cross-reactive?Nature Reviews Immunology, 2012
- The route of priming influences the ability of respiratory virus–specific memory CD8+ T cells to be activated by residual antigenJournal of Experimental Medicine, 2010
- Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever VaccinesImmunity, 2008
- Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosisJournal of Clinical Investigation, 2005
- Memory CD8 T-Cell Differentiation during Viral InfectionJournal of Virology, 2004
- Duration of antiviral immunity after smallpox vaccinationNature Medicine, 2003
- Human Papillomavirus Type 16 E7 Peptide-Directed CD8+T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 ProteinJournal of Virology, 2003
- A Direct Estimate of the Human αβ T Cell Receptor DiversityScience, 1999
- HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian womenNature Medicine, 1995